Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sagimet Biosciences Inc shares valued at $289,979 were sold by Kemble George on Nov 20 ’25. At $7.69 per share, Kemble George sold 37,688 shares. The insider’s holdings dropped to 81,005 shares worth approximately $0.52 million following the completion of this transaction.
Also, GEORGE KEMBLE purchased 37,688 shares, netting a total of over 295,851 in proceeds.
Before that, Happel David had sold 65,478 shares from its account. In a trade valued at $598,115, the President & CEO traded Sagimet Biosciences Inc shares for $9.13 each. Upon closing the transaction, the insider’s holdings decreased to 65,478 shares, worth approximately $4.46 million.
As published in their initiating research note from Wedbush on August 11, 2025, Sagimet Biosciences Inc [SGMT] has been an Outperform and the price target has been revised to $28. As of July 24, 2025, Canaccord Genuity has initiated its “Buy” rating for SGMT. Earlier on December 06, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for SGMT stock.
Analyzing SGMT Stock Performance
On last trading session, Sagimet Biosciences Inc [NASDAQ: SGMT] rose 6.16% to $6.46. The stock’s lowest price that day was $6.08, but it reached a high of $6.47 in the same session. During the last five days, there has been a drop of approximately -7.45%. Over the course of the year, Sagimet Biosciences Inc shares have jumped approximately 13.53%. Shares of the company reached a 52-week high of $11.41 on 07/25/25 and a 52-week low of $1.73 on 04/07/25.
Support And Resistance Levels for Sagimet Biosciences Inc (SGMT)
According to the 24-hour chart, there is a support level at 6.20, which, if violated, would cause prices to drop to 5.95. In the upper region, resistance lies at 6.59. The next price resistance is at 6.73. RSI (Relative Strength Index) is 39.69 on the 14-day chart, showing neutral technical sentiment.
Is Sagimet Biosciences Inc subject to short interest?
Stocks of Sagimet Biosciences Inc saw a sharp rise in short interest on 2025-11-14 jumping by 0.24 million shares to 2.99 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 2.75 million shares. A jump of 7.98% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.24 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.24.
Which companies own the most shares of Sagimet Biosciences Inc (SGMT)?
In terms of Sagimet Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, down nearly -1.48% from the previous closing price of $6.09. Analysts anticipate Sagimet Biosciences Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 5 analysts ranked Sagimet Biosciences Inc stock as Buy at the end of 2025. On November 12, 2024, UBS assigned a price target of “a Buy” to the stock and initiated coverage with a $12.
